Category: Markets
Published: 2026-06-22T14:23:03.000Z
AbbVie announced its agreement to acquire Apogee Therapeutics for approximately $10.9 billion. This acquisition is not a new strategic direction for AbbVie but rather a move to strengthen its existing immunology portfolio, which has been central to the drugmaker's reputation.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.